Urothelial Carcinoma of the Renal Pelvis and Ureter Clinical Trials

9 clinical trials for Urothelial Carcinoma of the Renal Pelvis and Ureter across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma — RECRUITING · PHASE2
• Bladder EpiCheck European Haematuria Study — RECRUITING
• Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma — RECRUITING · PHASE2
• 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma — RECRUITING · PHASE2
• uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto — RECRUITING
• Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 ) — NOT_YET_RECRUITING · PHASE2
• Named Patient Program for Mitomycin for Pyelocalyceal Solution — OTHER
• Neoadjuvant Radiotherapy for High-risk UTUC — NOT_YET_RECRUITING
• A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma — TERMINATED · PHASE2

Refine this search